Low Hemoglobin Levels Are Associated with Reduced Psychomotor and Language Abilities in Young Ugandan Children

Margaret Nampijja1,2, Agnes M Mutua3, Alison M Elliott2,4

  • 1Maternal and Child Wellbeing (MCW) Unit, African Population and Health Research Center, Nairobi 00100, Kenya.

Nutrients
|April 12, 2022
PubMed

Insights

Maternal and child anemia in Sub-Saharan Africa is linked to lower psychomotor and language development in early childhood. Further research is needed on iron deficiency impacts on neurodevelopment.

Area of Science:

  • Neuroscience
  • Developmental Pediatrics
  • Public Health

Background:

  • Children in Sub-Saharan Africa face developmental delays due to disease and malnutrition.
  • Anemia and iron deficiency (ID) are common in pregnant women and young children, impacting brain development.
  • Limited evidence exists on anemia, ID, and neurodevelopment in this region.

Purpose of the Study:

  • To examine the association between maternal and child hemoglobin (Hb) levels and iron status with neurodevelopmental outcomes in Ugandan children.
  • To investigate the impact of anemia and iron deficiency on psychomotor, cognitive, and language development.

Main Methods:

  • Prospective birth cohort study (Entebbe Mother and Baby Study) in Uganda.
  • Analysis of data from 933 and 530 preschool children.
  • Regression analyses adjusted for confounders to assess Hb levels, iron status, and developmental scores.

Main Results:

  • Lower maternal and child Hb levels correlated with reduced psychomotor scores at 15 months.
  • Lower infant Hb levels were associated with reduced language scores.
  • No significant association found between anemia or ID and cognitive/motor scores at five years.

Conclusions:

  • Managing anemia during pregnancy and infancy is crucial for child development.
  • Further research is necessary to understand the long-term effects of anemia and iron deficiency in Sub-Saharan African children.

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.3K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.7K
Factors Affecting Respiration01:24

Factors Affecting Respiration

Respiration is a crucial physiological function involving exchanging oxygen (O2) and carbon dioxide (CO2) between an organism and its environment. Various factors can impact this essential process:
7.7K
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
15.8K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
289